Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks
- 28 March 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (5) , 1351-1358
- https://doi.org/10.1016/s0735-1097(01)01128-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic PatientsCirculation, 1998
- Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medicationThe Lancet, 1995
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.Journal of Clinical Investigation, 1995
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionNew England Journal of Medicine, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMPAmerican Journal of Physiology-Cell Physiology, 1994
- Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993